CONMED Profit Margin 2006-2018 | CNMD

Current and historical gross margin, operating margin and net profit margin for CONMED (CNMD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. CONMED net profit margin as of June 30, 2018 is 8.85%.
CONMED Annual Profit Margins
CONMED Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical MED/DENTAL-SUPP $2.094B $0.796B
CONMED Corporation is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. The Company distributes its products worldwide from several manufacturing locations.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) US $65.548B 23.47
McKesson (MCK) US $26.977B 10.32
Align Technology (ALGN) US $26.733B 71.27
AmerisourceBergen (ABC) US $20.286B 14.74
Laboratory Of America Holdings (LH) US $17.740B 16.32
Cardinal Health (CAH) US $16.049B 11.15
Henry Schein (HSIC) US $13.240B 22.58
Cooper (COO) US $12.987B 23.39
West Pharmaceutical Services (WST) US $8.746B 45.22
Merit Medical Systems (MMSI) US $3.555B 46.73
Patterson (PDCO) US $2.321B 16.31
STAAR Surgical (STAA) US $1.887B 252.65
Atrion (ATRI) US $1.287B 38.14
Antares Pharma (ATRS) US $0.560B 0.00
Invacare (IVC) US $0.488B 0.00
Lifevantage (LFVN) US $0.153B 21.76
Endologix (ELGX) US $0.147B 0.00
Aceto (ACET) US $0.069B 44.60
Pro-Dex (PDEX) US $0.042B 26.32
Biolase (BIOL) US $0.028B 0.00
Retractable Technologies (RVP) US $0.023B 0.00
Milestone Scientific (MLSS) US $0.022B 0.00